Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma
Study sponsor: Geron Corporation
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2014-11Actual
Enrollment · participants13Actual
Source updated2026-06-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.